The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cervical Intraepithelial Neoplasia

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cervical Intraepithelial Neoplasia


High impact information on Cervical Intraepithelial Neoplasia


Chemical compound and disease context of Cervical Intraepithelial Neoplasia


Biological context of Cervical Intraepithelial Neoplasia


Anatomical context of Cervical Intraepithelial Neoplasia


Gene context of Cervical Intraepithelial Neoplasia


Analytical, diagnostic and therapeutic context of Cervical Intraepithelial Neoplasia


  1. Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity. Hu, X., Pang, T., Asplund, A., Pontén, J., Nistér, M. J. Exp. Med. (2002) [Pubmed]
  2. Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus. Walker, F., Kermorgant, S., Daraï, E., Madelenat, P., Cremieux, A.C., Hénin, D., Lehy, T. Clin. Cancer Res. (2003) [Pubmed]
  3. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. Vessey, C.J., Wilding, J., Folarin, N., Hirano, S., Takeichi, M., Soutter, P., Stamp, G.W., Pignatelli, M. J. Pathol. (1995) [Pubmed]
  4. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Wang, J.L., Zheng, B.Y., Li, X.D., Angström, T., Lindström, M.S., Wallin, K.L. Clin. Cancer Res. (2004) [Pubmed]
  5. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. Cason, J., Kambo, P.K., Best, J.M., McCance, D.J. Int. J. Cancer (1992) [Pubmed]
  6. The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions. Ndisdang, D., Morris, P.J., Chapman, C., Ho, L., Singer, A., Latchman, D.S. J. Clin. Invest. (1998) [Pubmed]
  7. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. Obermair, A., Bancher-Todesca, D., Bilgi, S., Kaider, A., Kohlberger, P., Müllauer-Ertl, S., Leodolter, S., Gitsch, G. J. Natl. Cancer Inst. (1997) [Pubmed]
  8. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. Meyskens, F.L., Surwit, E., Moon, T.E., Childers, J.M., Davis, J.R., Dorr, R.T., Johnson, C.S., Alberts, D.S. J. Natl. Cancer Inst. (1994) [Pubmed]
  9. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. Meyskens, F.L., Graham, V., Chvapil, M., Dorr, R.T., Alberts, D.S., Surwit, E.A. J. Natl. Cancer Inst. (1983) [Pubmed]
  10. Diagnostic significance of octadeca-9,11-dienoic acid in cervical neoplasia. Green, A.J., Starkey, B.J., Halloran, S.P., McKee, G., Sutton, C.J., Manners, B.T., Walker, A.W. Lancet (1988) [Pubmed]
  11. Ultrastructural and morphometric study of diethylstilbestrol-associated lesions diagnosed as cervical intraepithelial neoplasia III. Lawrence, W.D., Shingleton, H.M., Gore, H., Soong, S.J. Cancer Res. (1980) [Pubmed]
  12. Quantitative measurements of the changes in protein thiols in cervical intraepithelial neoplasia and in carcinoma of the human uterine cervix provide evidence for the existence of a biochemical field effect. Benedetto, C., Bajardi, F., Ghiringhello, B., Marozio, L., Nöhammer, G., Phitakpraiwan, P., Rojanapo, W., Schauenstein, E., Slater, T.F. Cancer Res. (1990) [Pubmed]
  13. Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Hillemanns, P., Tannous-Khuri, L., Koulos, J.P., Talmage, D., Wright, T.C. Am. J. Pathol. (1992) [Pubmed]
  14. Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene. Comerci, J.T., Runowicz, C.D., Fields, A.L., Romney, S.L., Palan, P.R., Kadish, A.S., Goldberg, G.L. Clin. Cancer Res. (1997) [Pubmed]
  15. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Mitchell, M.F., Tortolero-Luna, G., Lee, J.J., Hittelman, W.N., Lotan, R., Wharton, J.T., Hong, W.K., Nishioka, K. Clin. Cancer Res. (1998) [Pubmed]
  16. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. Butler, D., Collins, C., Mabruk, M., Barry Walsh, C., Leader, M.B., Kay, E.W. J. Pathol. (2000) [Pubmed]
  17. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. Terry, G., Ho, L., Londesborough, P., Cross, P., Lopes, A., Monaghan, J., Cuzick, J. Br. J. Cancer (2004) [Pubmed]
  18. Expression of human papillomavirus type 16 E6-E7 open reading frame varies quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. McNicol, P., Guijon, F., Wayne, S., Hidajat, R., Paraskevas, M. J. Clin. Microbiol. (1995) [Pubmed]
  19. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking. Warwick, A.P., Redman, C.W., Jones, P.W., Fryer, A.A., Gilford, J., Alldersea, J., Strange, R.C. Br. J. Cancer (1994) [Pubmed]
  20. Differential expression of cytokine genes in cervical cancer tissues. Pao, C.C., Lin, C.Y., Yao, D.S., Tseng, C.J. Biochem. Biophys. Res. Commun. (1995) [Pubmed]
  21. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Dillner, J., Dillner, L., Robb, J., Willems, J., Jones, I., Lancaster, W., Smith, R., Lerner, R. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  22. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Smedts, F., Ramaekers, F., Robben, H., Pruszczynski, M., van Muijen, G., Lane, B., Leigh, I., Vooijs, P. Am. J. Pathol. (1990) [Pubmed]
  23. Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells. Davidson, E.J., Brown, M.D., Burt, D.J., Parish, J.L., Gaston, K., Kitchener, H.C., Stacey, S.N., Stern, P.L. Int. J. Cancer (2001) [Pubmed]
  24. Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Jonas, S.K., Benedetto, C., Flatman, A., Hammond, R.H., Micheletti, L., Riley, C., Riley, P.A., Spargo, D.J., Zonca, M., Slater, T.F. Br. J. Cancer (1992) [Pubmed]
  25. Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia. Cornelissen, M.T., van den Tweel, J.G., Struyk, A.P., Jebbink, M.F., Briët, M., van der Noordaa, J., ter Schegget, J.T. J. Gen. Virol. (1989) [Pubmed]
  26. Cyclooxygenase-2 is overexpressed in human cervical cancer. Kulkarni, S., Rader, J.S., Zhang, F., Liapis, H., Koki, A.T., Masferrer, J.L., Subbaramaiah, K., Dannenberg, A.J. Clin. Cancer Res. (2001) [Pubmed]
  27. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Amortegui, A.J., Meyer, M.P., Elborne, V.L., Amin, R.M. Mod. Pathol. (1995) [Pubmed]
  28. Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Murphy, N., Ring, M., Heffron, C.C., Martin, C.M., McGuinness, E., Sheils, O., O'Leary, J.J. Mod. Pathol. (2005) [Pubmed]
  29. E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: comparison between HIV-positive and HIV-negative women and correlation with HPV status. Daraï, E., Walker-Combrouze, F., Bénifla, J.L., Hénin, D., Feldmann, G., Madelenat, P., Scoazec, J.Y. Gynecol. Oncol. (2000) [Pubmed]
  30. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. Reesink-Peters, N., Helder, M.N., Wisman, G.B., Knol, A.J., Koopmans, S., Boezen, H.M., Schuuring, E., Hollema, H., de Vries, E.G., de Jong, S., van der Zee, A.G. J. Clin. Pathol. (2003) [Pubmed]
  31. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial. Boiko, I.V., Mitchell, M.F., Hu, W., Pandey, D.K., Mathevet, P., Malpica, A., Hittelman, W.N. Clin. Cancer Res. (1998) [Pubmed]
  32. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Hillemanns, P., Korell, M., Schmitt-Sody, M., Baumgartner, R., Beyer, W., Kimmig, R., Untch, M., Hepp, H. Int. J. Cancer (1999) [Pubmed]
  33. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Sankaranarayanan, R., Chatterji, R., Shastri, S.S., Wesley, R.S., Basu, P., Mahe, C., Muwonge, R., Seigneurin, D., Somanathan, T., Roy, C., Kelkar, R., Chinoy, R., Dinshaw, K., Mandal, R., Amin, G., Goswami, S., Pal, S., Patil, S., Dhakad, N., Frappart, L., Fontaniere, B. Int. J. Cancer (2004) [Pubmed]
  34. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. Müller, M., Viscidi, R.P., Ulken, V., Bavinck, J.N., Hill, P.M., Fisher, S.G., Reid, R., Munoz, N., Schneider, A., Shah, K.V. J. Invest. Dermatol. (1995) [Pubmed]
  35. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Hopman, A.H., Kamps, M.A., Smedts, F., Speel, E.J., Herrington, C.S., Ramaekers, F.C. Int. J. Cancer (2005) [Pubmed]
WikiGenes - Universities